Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 34 of 34 entries
View as:

A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT04735393 Org: User:
Start: 01/26/21 End: 10/11/22 Due: 10/11/23

A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT06424444 Org: User:
Start: 04/29/24 End: 11/03/24 Due: 11/03/25

A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT06493604 Org: User:
Start: 06/24/24 End: 02/27/25 Due: 02/27/26

SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.

Phase: N/A Priority: Normal
NCT ID: NCT03131154 Org: User:
Start: 04/26/17 End: 04/26/19 Due: 04/26/20

The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT04674358 Org: User:
Start: 11/21/20 End: 09/12/21 Due: 09/12/22

A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT03916042 Org: User:
Start: 04/23/19 End: 11/22/19 Due: 11/22/20

RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

Phase: N/A Priority: Normal
NCT ID: NCT03445650 Org: User:
Start: 07/18/18 End: 01/18/20 Due: 01/18/21

A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)

Phase: N/A Priority: Normal
NCT ID: NCT06685692 Org: User:
Start: 11/04/24 End: 12/31/25 Due: 12/31/26

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT03404115 Org: User:
Start: 01/02/18 End: 07/11/18 Due: 07/11/19